Cx Daily Eye Protector
FDA Label NDC 49527-750

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Clinique Laboratories Inc for the product Cx Daily Eye Protector (NDC 49527-750). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, warnings, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

active ingredient: titanium dioxide 7.80%

Inactive Ingredient

inactive ingredients: cyclopentasiloxane [] dimethicone [] trioctyldodecyl citrate [] silica [] isododecane [] vinyl dimethicone/methicone silsesquioxane crosspolymer [] dimethicone/vinyl dimethicone crosspolymer [] trimethylsiloxysilicate [] polysilicone-11 [] aluminum stearate [] mimosa tenuiflora bark extract [] tocopheryl acetate [] vitis vinifera (grape) seed oil [] 7-dehydrocholesterol [] tricaprylin [] tetrahexyldecyl ascorbate [] butylene glycol [] water\aqua\eau [] tocotrienols [] aminopropyl ascorbyl phosphate [] stearic acid [] methicone [] phenoxyethanol [] mica [] iron oxides (ci 77491, ci 77492, ci 77499) [] titanium dioxide (ci 77891)

Warnings

warning: keep out of eyes. stop use if irritation occurs. keep out of reach of children

Package Label.Principal Display Panel

PRINCIPAL DISPLAY PANEL FOR OTC SUNSCREEN PRODUCT INCLUDED IN SET. SET ALSO CONTAINS A COSMETIC PRODUCT:


CLINIQUE


CX

24 HOUR EYE DE-AGING SYSTEM

DAILY EYE PROTECTOR

SPF 15



CLINIQUE LABORATORIES, INC

NEW YORK, NY 10022

Folding Carton (6x7c Page 1)

Folding Carton (6x7c Page 1)


* Please review the disclaimer below.